Paper Clips

The wellness M&A hot streak shows no signs of slowing down

Acquisitions in 2026 are proving to be all about health and wellness.

Last week, Procter & Gamble announced its acquisition of supplement brand Thorne for $3.8 billion, part of a wave of high-profile acquisitions in the wellness space. 

It’s another strong signal that large CPG conglomerates are increasingly seeking out science-backed, high-growth brands to add to their portfolios as consumer priorities shift toward longevity, functional health and the nutritional demands of the growing GLP-1 user base. The Thorne buyout is the latest high-profile supplement acquisition of 2026. Earlier this year, three-year-old gummy multivitamins startup Grüns was acquired by Unilever for an undisclosed figure. 

The P&G deal comes after a series of ownership shifts for Thorne, including an IPO in 2021. Since then, the company, founded in 1984, was taken private by L Catterton in a deal valued at $680 million. According to Thorne, its annual revenue surpassed $500 million in 2025.

The wellness M&A hot streak shows no signs of slowing down

Back To Top
×Close search
Search